Natco Pharma’s Generic Semaglutide Set for Roll Out Today

Natco Pharma’s generic Semaglutide set for roll out today

Natco Pharma will launch its Semaglutide injection (multi dose vials) in the domestic market on Saturday.

Natco Pharma shares rise 2.5% as firm launches Semaglutide generic injection multi-dose vials in India

Multi-dose vials will be launched at MRP of Rs 1,290 per month for 2 mg/1.5ml & 4mg/3ml and MRP of Rs 1,750 for 8mg/3ml, said Natco Pharma

Indian drugmakers roll out generic Semaglutide shots for Diabetes care

New Delhi: Three Indian pharmaceutical companies have launched generic versions of semaglutide injections, after the drug’s patent expired, offering lower‑cost options for patients managing Type 2 diabetes and obesity.  The companies, namely Sun Pharma, Zydus Lifesciences, and Dr. Reddy's Laboratories, launched their variants a day after Hyderabad-based Natco Pharma launched its generic semaglutide injection in India, priced at Rs 1,290 per mont…

Indian Pharma Giants Launch Low-Cost Generic Semaglutide - Business League

The “Weight Loss Revolution” has officially become affordable in India. As of today, March 21, 2026, the high barrier to entry for semaglutide—a drug that has transformed the global management of obesity and diabetes—has been dismantled by Indian generic manufacturers. Also Read |Tamil Nadu Voter List Purge: 97 Lakh Names Deleted in SIR Phase 1 Brand & Pricing Comparison The market is seeing an immediate “price war” between four major entities. …

Indian pharma firms launch cheaper generic semaglutide for diabetes, obesity

Sun Pharma, Zydus Lifesciences, and Dr. Reddy's Laboratories launched their products a day after Natco Pharma introduced its version priced at about Rs 1,290 per month.

Zydus Launches Semaglutide Injection in an Innovative, Reusable Multi-Dose Pen Device in India

Business Wire India The novel pen device will be available for patients in a prefilled cartridge administered using a patient-friendly reusable pen for which the company has exclusive rights The drug will be launched under the brand names – SEMAGLYN TM, MASHEMA TM and ALTERME TM Zydus Lifesciences Limited (including its subsidiaries, hereafter referred to as “Zydus”), an innovation-led global lifesciences company, has launched Semaglutide Injec…